CIK 0001398733 · Non-accelerated filer<br>Smaller reporting company
Aquestive Therapeutics, Inc.
Sign in to watch- Ticker
- AQST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208623253
- Phone
- 908-941-1900
- Business address
- 184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
- Former names
- MonoSol Rx, Inc.
- 4 Open-market buy Director bought 28,025 shares at an average $3.54 ($99,331)
- 4 Shares withheld for taxes Chief Development Officer gave up 5,303 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Other acquisition Director acquired 62,229 shares (other)
- 4 Planned sale President and CEO sold 25,000 shares at $4.22 ($105,600)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale President and CEO sold 25,000 shares at $4.82 ($120,488)
- 4 Planned sale Chief Commercial Officer sold 8,750 shares at $5.22 ($45,675)
- 4 Option exercise Chief People Officer acquired 2,293 shares (option exercise)
- 4 Option exercise President and CEO acquired 91,743 shares (option exercise)
- 4 Option exercise Chief Operating Officer acquired 4,587 shares (option exercise)
- 4 Planned sale President and CEO sold 25,000 shares at $4.29 ($107,168)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 2,714 shares (to pay taxes)
- 4 Planned sale President and CEO sold 25,000 shares at an average $4.01 ($100,192)
- 4 Planned sale Director sold 25,000 shares at $5.02 ($125,393)
- 4 Planned sale President and CEO sold 25,000 shares at $4.16 ($104,010)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 1 of 17 · 325 filings